Hepatitis C virus infection

Seminars in Fetal and Neonatal Medicine

Volumn 12, Issue 3, 2007, Pages 168-173

  Fischler, Björn ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antiviral treatment; Hepatitis C; Liver damage; Risk factors; Transmission

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; RIBAVIRIN;

BREAST FEEDING; CHRONIC DISEASE; COMORBIDITY; DISEASE COURSE; DRUG EFFICACY; HEPATITIS C; HEPATITIS C VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LIVER INJURY; OBSTETRIC CARE; PEDIATRICIAN; PREGNANT WOMAN; PREVALENCE; REVIEW; RISK FACTOR; SEX DIFFERENCE; VIRUS TRANSMISSION;

DISEASE TRANSMISSION, VERTICAL; FEMALE; HEPATITIS C; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 34247596545     PISSN: 1744165X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.siny.2007.01.008     Document Type: Review

References (53)

1. Choo Q.L., Kuo G., Weiner A.J., Overby L.R., Bradley D.W., and Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244 4902 (1989) 359-362
2. Alter M.J. Epidemiology of hepatitis C in the West. Semin Liver Dis 15 1 (1995) 5-14
3. Di Bisceglie A.M., Simpson L.H., Lotze M.T., and Hoofnagle J.H. Development of hepatocellular carcinoma among patients with chronic liver disease due to hepatitis C viral infection. J Clin Gastroenterol 19 3 (1994) 222-226
4. Slowik M.K., and Jhaveri R. Hepatitis B and C viruses in infants and young children. Semin Pediatr Infect Dis 16 4 (2005) 296-305
5. Mansell C.J., and Locarnini S.A. Epidemiology of hepatitis C in the East. Semin Liver Dis 15 1 (1995) 15-32
6. Frank C., Mohamed M.K., Strickland G.T., Lavanchy D., Arthur R.R., Magder L.S., et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 355 9207 (2000) 887-891
7. Roberts E.A., and Yeung L. Maternal-infant transmission of hepatitis C virus infection. Hepatology 36 5 Suppl. 1 (2002) S106-S113
8. Jabeen T., Cannon B., Hogan J., Crowley M., Devereux C., Fanning L., et al. Pregnancy and pregnancy outcome in hepatitis C type 1b. Qjm 93 9 (2000) 597-601
9. Jaffery T., Tariq N., Ayub R., and Yawar A. Frequency of hepatitis C in pregnancy and pregnancy outcome. J Coll Physicians Surg Pak 15 11 (2005) 716-719
10. Ohto H., Terazawa S., Sasaki N., Hino K., Ishiwata C., Kako M., et al. Transmission of hepatitis C virus from mothers to infants. The Vertical Transmission of Hepatitis C Virus Collaborative Study Group. N Engl J Med 330 11 (1994) 744-750
11. Thomas S.L., Newell M.L., Peckham C.S., Ades A.E., and Hall A.J. A review of hepatitis C virus (HCV) vertical transmission: risks of transmission to infants born to mothers with and without HCV viraemia or human immunodeficiency virus infection. Int J Epidemiol 27 1 (1998) 108-117
12. Resti M., Azzari C., Mannelli F., Moriondo M., Novembre E., de Martino M., et al. Mother to child transmission of hepatitis C virus: prospective study of risk factors and timing of infection in children born to women seronegative for HIV-1. Tuscany Study Group on Hepatitis C Virus Infection. BMJ 317 7156 (1998) 437-441
13. European paediatric HCV network (EPHN). A significant sex - but not elective Cesarean section - effect on mother-to-child transmission of hepatitis C infection. J Infect Dis 192 (2005) 1872-1879
14. Resti M., Bortolotti F., Azzari C., Giacchino R., Zancan L., Gussetti N., et al. Transmission of hepatitis C virus from infected mother to offspring during subsequent pregnancies. J Pediatr Gastroenterol Nutr 30 5 (2000) 491-493
15. European paediatric HCV network (EPHN), England K., Pembrey L., Tovo P.A., and Newell M.L. Excluding hepatitis C virus (HCV) infection by serology in young infants of HCV-infected mothers. Acta Paediatr 94 4 (2005) 444-450
16. Azzari C., Resti M., Moriondo M., Ferrari R., Lionetti P., and Vierucci A. Vertical transmission of HCV is related to maternal peripheral blood mononuclear cell infection. Blood 96 6 (2000) 2045-2048
17. Della Bella S., Riva A., Tanzi E., Nicola S., Amendola A., Vecchi L., et al. Hepatitis C virus-specific reactivity of CD4+-lymphocytes in children born from HCV-infected women. J Hepatol 43 3 (2005) 394-402
18. Resti M., Azzari C., Galli L., Zuin G., Giacchino R., Bortolotti F., et al. Maternal drug use is a preeminent risk factor for mother-to-child hepatitis C virus transmission: results from a multicenter study of 1372 mother-infant pairs. J Infect Dis 185 5 (2002) 567-572
19. European paediatric HCV network (EPHN), Mok J., Pembrey L., Tovo P.A., and Newell M.L. When does mother to child transmission of hepatitis C virus occur?. Arch Dis Child Fetal Neonatal Ed 90 2 (2005) F156-F160
20. Gibb D.M., Goodall R.L., Dunn D.T., Healy M., Neave P., Cafferkey M., et al. Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission. Lancet 356 9233 (2000) 904-907
21. European paediatric HCV network (EPHN). Effects of mode of delivery and infant feeding on the risk of mother- to- child transmission of hepatitis C virus. Brit J Obstetr Gynaecol 78 (2001) 371-377
22. Delamare C., Carbonne B., Heim N., Berkane N., Petit J.C., Uzan S., et al. Detection of hepatitis C virus RNA (HCV RNA) in amniotic fluid: a prospective study. J Hepatol 31 3 (1999) 416-420
23. Mast E.E., Hwang L.Y., Seto D.S., Nolte F.S., Nainan O.V., Wurtzel H., et al. Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. J Infect Dis 192 11 (2005) 1880-1889
24. Taha T.E., Nour S., Kumwenda N.I., Broadhead R.L., Fiscus S.A., Kafulafula G., et al. Gender differences in perinatal HIV acquisition among African infants. Pediatrics 115 2 (2005) e167-e172
25. Kumar R.M., and Shahul S. Role of breast-feeding in transmission of hepatitis C virus to infants of HCV-infected mothers. J Hepatol 29 2 (1998) 191-197
26. Lin H.H., Kao J.H., Hsu H.Y., Ni Y.H., Chang M.H., Huang S.C., et al. Absence of infection in breast-fed infants born to hepatitis C virus-infected mothers. J Pediatr 126 4 (1995) 589-591
27. Polywka S., Schroter M., Feucht H.H., Zollner B., and Laufs R. Low risk of vertical transmission of hepatitis C virus by breast milk. Clin Infect Dis 29 5 (1999) 1327-1329
28. European paediatric HCV network (EPHN), Polywka S., Pembrey L., Tovo P.A., and Newell M.L. Accuracy of HCV-RNA PCR tests for diagnosis or exclusion of vertically acquired HCV infection. J Med Virol 78 2 (2006) 305-310
29. European paediatric HCV network (EPHN), Pembrey L., Newell M.L., and Tovo P.A. The management of HCV infected pregnant women and their children. European paediatric HCV network. J Hepatol 43 (2005) 515-525
30. Leonardi S., Avola E., Sciacca A., Di Gregorio F., and Musumeci S. Neopterin as a marker of C hepatitis in thalassaemia major. J Pediatr Gastroenterol Nutr 12 3 (1991) 315-318
31. Locasciulli A., Bacigalupo A., Vanlint M.T., Tagger A., Uderzo C., Portmann B., et al. Hepatitis C virus infection in patients undergoing allogeneic bone marrow transplantation. Transplantation 52 2 (1991) 315-318
32. Jonas M.M., Zilleruelo G.E., LaRue S.I., Abitbol C., Strauss J., and Lu Y. Hepatitis C infection in a pediatric dialysis population. Pediatrics 89 4 Pt 2 (1992) 707-709
33. Romano L., Azara A., Chiaramonte M., De Mattia D., Giammanco A., Moschen M.E., et al. Low prevalence of anti-HCV antibody among Italian children. Infection 22 5 (1994) 350-352
34. Jonas M.M., Robertson L.M., and Middleman A.B. Low prevalence of antibody to hepatitis C virus in an urban adolescent population. J Pediatr 131 2 (1997) 314-316
35. Tanaka E., Kiyosawa K., Sodeyama T., Hayata T., Ohike Y., Nakano Y., et al. Prevalence of antibody to hepatitis C virus in Japanese schoolchildren: comparison with adult blood donors. Am J Trop Med Hyg 46 4 (1992) 460-464
36. Ramirez-Mayans J., Cervantes-Bustamante R., Zarate-Mondragon F., Mata-Rivera N., Tello M., Navarrete N., et al. Hepatitis C virus antibodies in a Mexican population. Pediatr Infect Dis J 17 2 (1998) 169-170
37. el-Nanawy A.A., el Azzouni O.F., Soliman A.T., Amer A.E., Demian R.S., and el-Sayed H.M. Prevalence of hepatitis-C antibody seropositivity in healthy Egyptian children and four high risk groups. J Trop Pediatr 41 6 (1995) 341-343
38. al-Faleh F.Z., Ayoola E.A., al-Jeffry M., al-Rashed R., al-Mofarreh M., Arif M., et al. Prevalence of antibody to hepatitis C virus among Saudi Arabian children: a community-based study. Hepatology 14 2 (1991) 215-218
39. Ngatchu T., Stroffolini T., Rapicetta M., Chionne P., Lantum D., and Chiaramonte M. Seroprevalence of anti-HCV in an urban child population: a pilot survey in a developing area, Cameroon. J Trop Med Hyg 95 1 (1992) 57-61
40. Bortolotti F., Resti M., Giacchino R., Crivellaro C., Zancan L., Azzari C., et al. Changing epidemiologic pattern of chronic hepatitis C virus infection in Italian children. J Pediatr 133 3 (1998) 378-381
41. Vogt M., Lang T., Frosner G., Klingler C., Sendl A.F., Zeller A., et al. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Engl J Med 341 12 (1999) 866-870
42. Gonzalez-Peralta R.P., Andres J.M., Fang J.W., Qian K.P., Lau J.Y., Quan S., et al. Hepatitis C virus infection in pediatric cholestatic diseases. J Pediatr Gastroenterol Nutr 21 2 (1995) 240-242
43. European paediatric HCV network (EPHN). Three broad modalities in the natural history of vertically acquired hepatitis C virus infection. Clin Infect Dis 41 1 (2005) 45-51
44. Lai M.E., De Virgilis S., Argiolu F., Farci P., Mazzoleni A.P., Lisci V., et al. Evaluation of antibodies to hepatitis C virus in a long-term prospective study of posttransfusion hepatitis among thalassemic children: comparison between first- and second-generation assay. J Pediatr Gastroenterol Nutr 16 4 (1993) 458-464
45. Inui A., Fujisawa T., Miyagawa Y., Sekine I., Hanada R., Yamamoto K., et al. Histologic activity of the liver in children with transfusion-associated chronic hepatitis C. J Hepatol 21 5 (1994) 748-753
46. Jara P., Resti M., Hierro L., Giacchino R., Barbera C., Zancan L., et al. Chronic hepatitis C virus infection in childhood: clinical patterns and evolution in 224 white children. Clin Infect Dis 36 3 (2003) 275-280
47. Manns M.P., McHutchison J.G., Gordon S.C., Rustgi V.K., Shiffman M., Reindollar R., et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358 9286 (2001) 958-965
48. Jacobson K.R., Murray K., Zellos A., and Schwarz K.B. An analysis of published trials of interferon monotherapy in children with chronic hepatitis C. J Pediatr Gastroenterol Nutr 34 1 (2002) 52-58
49. Wirth S., Lang T., Gehring S., and Gerner P. Recombinant alfa-interferon plus ribavirin therapy in children and adolescents with chronic hepatitis C. Hepatology 36 5 (2002) 1280-1284
50. Gonzalez-Peralta R.P., Kelly D.A., Haber B., Molleston J., Murray K.F., Jonas M.M., et al. Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: Efficacy, safety, and pharmacokinetics. Hepatology 42 5 (2005) 1010-1018
51. Wirth S., Pieper-Boustani H., Lang T., Ballauff A., Kullmer U., Gerner P., et al. Peginterferon alfa-2b plus ribavirin treatment in children and adolescents with chronic hepatitis C. Hepatology 41 5 (2005) 1013-1018
52. Iorio R., Pensati P., Botta S., Moschella S., Impagliazzo N., Vajro P., et al. Side effects of alpha-interferon therapy and impact on health-related quality of life in children with chronic viral hepatitis. Pediatr Infect Dis J 16 10 (1997) 984-990
53. The important references are indicated with asterisks